NOT_YET_RECRUITING
Implementation of Collaborative Care for Depression in VA HIV Clinics
HIV Translating Initiatives for Depression into Effective Solutions (HITIDES) is a team-based service to manage depression in Veterans Living with HIV (VLWH). This service is more effective for managing depression than the care VLWH usually receive and saves resources. HITIDES is also liked by HIV care providers and VLWH. Despite this, no VA clinics currently offer this service. This study examines two approaches to engage clinics with HITIDES, the resulting effects on VLWH, and the costs of these approaches. The first approach includes recruiting an HIV care provider at the site to help connect with the service and a network of providers to support this person. The second approach uses an additional external expert to facilitate these connections. Understanding how to connect Veterans to the HITIDES service will allow VA to improve depression care for VLWH and save VA resources.
Conditions:
🦠 HIV 🦠 Depression
🗓️ Study Start (Actual) 1 August 2024
🗓️ Primary Completion (Estimated) 31 July 2026
✅ Study Completion (Estimated) 31 July 2027
👥 Enrollment (Estimated) 8
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 North Little Rock, Arkansas, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • The research team will work with VISN 10 to identify sites that
    • * have an adequately sized (i.e. greater than 20) population of Veterans Living with HIV,
    • * have adequate PHQ-2 screen data to assess depression prevalence,
    • * can identify a clinical champion for implementation activities,
    • * are willing to participate, and
    • * allow for diversity and balance of clinic characteristics across arms (e.g. rate of referral to specialty mental health for VLWH and presence of HIV-only specialty clinic versus broad infectious disease clinic).
    • * For criterion 5, these factors that are important will be determined with VISN 10 clinical leadership and the research advisory council. Randomization at the VAMC level has limited ability to completely balance observed and unobserved health-system factors. However, efforts to balance key site characteristics are important; therefore, site-level characteristics thought to impact implementation efforts were identified by building consensus among HIV, Hepatitis, and Related Conditions Program (HHRC) leadership and the HIV care and implementation experts on the research team. Data on the following observable site-level characteristics will be collected from these sites during Year 1 of the study: baseline PHQ-2 screen rate, clinic size (unique patients, provider full-time equivalents \[FTE\], change in enrollment over the past 3 years), and current care manager FTE. Based on the five criteria described above and the power calculation below, eight eligible sites will be selected. Sites will be grouped into four couplets based on balance of the identified site-level characteristics.

    Exclusion Criteria:

    • -None.
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 10 May 2023
  • First Submitted that Met QC Criteria 2 June 2023
  • First Posted 13 June 2023

Study Record Updates

  • Last Update Submitted that Met QC Criteria 19 April 2024
  • Last Update Posted 22 April 2024
  • Last Verified April 2024